Allogene Therapeutics
Price & Volume
Stats
See more52W Range | $1.78-$5.77 |
Market Cap | $392M |
Shares Short | 31M |
Financials
See moreRevenue (12 Mos) | $43,000 |
Revenue Growth (YoY) | -26.7% |
Gross Profit (12 Mos) | $243,000 |
Diluted EPS | -$1.55 |
News
See moreYahoo Finance • 3 months ago
Allogene Therapeutics, Inc. (ALLO): Among the Rising Penny Stocks to Invest In Now
Yahoo Finance • last year
Allogene Therapeutics, Inc. (NASDAQ:ALLO) Q3 2023 Earnings Call Transcript
About
CEO | Dr. David D. Chang M.D., Ph.D. |
CFO | Mr. Geoffrey M. Parker |
Address | 210 East Grand Avenue, South San Francisco, CA, United States, 94080 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 232 |
